Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have atrial fibrillation (an irregular heartbeat condition) and are between 18 and 79 years old, OR people between 40 and 79 years old who have been assessed as being at moderate or high risk for cardiovascular disease using a standard risk calculation tool called the ASCVD 10-year risk score.
- People who have internet and email access at home.
- People who own a compatible Android phone or tablet, or an Apple iPhone (4S or newer) or iPad (3rd generation or newer).
- People who are able and willing to visit the study clinic for a follow-up appointment and scan one year after their first scan.
- People who are able to read, understand, and sign a consent form.
Who may not be able to join:
- People who have a health-related reason they cannot safely have an MRI or receive gadolinium contrast dye — for example, an allergy to gadolinium, a pacemaker, an implanted heart device (ICD), or other implants that are not safe for use with MRI.
- People who weigh more than 300 pounds, as this can reduce the quality of MRI images.
- People whose kidneys are not working well enough (specifically, a kidney filtration rate below 30 mL/min/1.73m², or who have acute or severe kidney disease) (confirm with trial site).
- Women who are pregnant at the time of joining the trial. (Note: if a participant becomes pregnant during the study, no MRI scan will be performed until at least 10 days after giving birth.)
- People who do not have internet or email access at home.
- People who do not own a compatible Android or Apple mobile device as described above.
- People who have a cognitive (thinking or memory) impairment that would make it difficult to consistently wear and look after the wearable devices used in the study.
- People who are unable or unwilling to return to the study clinic for a follow-up visit one year after their first scan.
- People who have a cognitive impairment that prevents them from being able to give informed consent to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nassir F Marrouche, MD, Tulane University School of Medicine
Phone: 504-988-3063
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Atrial Myopathy Progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.